4 chapters across the catalog
The FDA and WHO are identified as the entities setting the cycle thresholds for PCR tests, with current recommendations reaching as high as 45 cycles. High cycle counts are blamed for creating false positives, while companies like Abbott Labs are noted for seeing double-digit stock growth linked to the rollout of testing apps and digital health passes.
A Thermo Fisher assay instruction sheet reportedly recommends 45 cycles for PCR testing, significantly higher than the standard 30 cycles. Maria Van Kerkhove of the World Health Organization defended the accuracy of PCR tests in a media briefing, emphasizing their global credibility. However, the lack of transparency regarding specific cycle counts used in different countries suggests a potential for manipulating data to justify lockdowns.
Faulty Chinese Antibody Tests and Gates Funding
An anonymous lab researcher reports that antibodies purchased from Beijing-based Sino Biological, a company funded by Bill Gates, were faulty and caused false positives in ELISA assays. The segment links these findings to reports from Roche's CEO regarding the poor quality of many COVID-19 antibody tests currently on the market. The hosts suggest the testing market is being manipulated with substandard Chinese products.
ELISA Assays and Specificity of Coronavirus Testing
The technical nature of ELISA (enzyme-linked immunosorbent assay) and PCR testing is examined, with concerns raised about the specificity of these tests for SARS-CoV-2. There is a suggestion that current tests might produce false positives by detecting other common coronavirus strains. The influence of the Gates Foundation on global testing narratives and data collection is also questioned.
